Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -79,875 | -52,106 | -22,906 | -64,486 | -45,561 |
| Depreciation Amortization | 2,308 | 2,419 | 420 | 2,468 | 2,026 |
| Accounts receivable | N/A | N/A | 2,514 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,444 | 6,962 | N/A | -650 | -680 |
| Other Working Capital | 6,261 | 10,976 | 5,509 | 2,891 | 2,105 |
| Other Operating Activity | 12,795 | 1,226 | 847 | 10,607 | 7,775 |
| Operating Cash Flow | $-57,067 | $-30,523 | $-13,616 | $-49,170 | $-34,335 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -281,332 | -152,042 | -66,533 | -48,826 | -37,989 |
| PPE Investments | -10,411 | -7,328 | -4,210 | -19,247 | -10,874 |
| Investing Cash Flow | $-291,743 | $-159,370 | $-70,743 | $-68,073 | $-48,863 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -29 | 0 | -27 | -112 | -84 |
| Common Stock Issued | 357,681 | 153,398 | 150,573 | 29,773 | 2,915 |
| Other Financing Activity | -2,043 | -2,043 | -1,922 | -1,470 | -1,411 |
| Financing Cash Flow | $355,609 | $151,355 | $148,624 | $28,191 | $1,420 |
| Beginning Cash Position | 66,896 | 66,896 | 66,896 | 155,948 | 155,948 |
| End Cash Position | 73,695 | 28,358 | 131,161 | 66,896 | 74,170 |
| Net Cash Flow | $6,799 | $-38,538 | $64,265 | $-89,052 | $-81,778 |
| Free Cash Flow | |||||
| Operating Cash Flow | -57,067 | -30,523 | -13,616 | -49,170 | -34,335 |
| Capital Expenditure | -10,411 | -7,328 | -4,210 | -19,247 | -10,874 |
| Free Cash Flow | -67,478 | -37,851 | -17,826 | -68,417 | -45,209 |